Chimeric antigens displaying GPR65 extracellular loops on a soluble scaffold enabled the discovery of antibodies, which recognized native receptor

Bioengineered. 2024 Dec;15(1):2299522. doi: 10.1080/21655979.2023.2299522. Epub 2024 Jan 7.

Abstract

GPR65 is a proton-sensing G-protein coupled receptor associated with multiple immune-mediated inflammatory diseases, whose function is relatively poorly understood. With few reagents commercially available to probe the biology of receptor, generation of an anti-GPR65 monoclonal antibody was desired. Using soluble chimeric scaffolds, such as ApoE3, displaying the extracellular loops of GPR65, together with established phage display technology, native GPR65 loop-specific antibodies were identified. Phage-derived loop-binding antibodies recognized the wild-type native receptor to which they had not previously been exposed, generating confidence in the use of chimeric soluble proteins to act as efficient surrogates for membrane protein extracellular loop antigens. This technique provides promise for the rational design of chimeric antigens in facilitating the discovery of specific antibodies to GPCRs.

Keywords: GPCR; GPR65; chimeric protein antigens; monoclonal antibody generation; phage display.

Plain language summary

This technique offers a viable approach for antibody discovery to difficult GPCRs.Structurally relevant, soluble chimeric scaffold proteins of GPR65 were generated.Chimeric antigens were used to identify GPR65-specific antibodies by phage display.

MeSH terms

  • Cell Surface Display Techniques*
  • Receptors, G-Protein-Coupled* / genetics
  • Technology

Substances

  • Receptors, G-Protein-Coupled

Grants and funding

The work described here was funded by UCB Pharma, with the following authors current employees Janine Barrett, Seppe Leysen, Cécile Galmiche, Thomas E. Edwards, Alastair D.G. Lawson, and Hussein Al-Mossawi a previous employee.ADGL and TEE hold shares and/or share options in UCB Pharma.PB received support from the NIHR Oxford Biomedical Research Centre (BRC). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.